k141_232407_6	megares|MEG_4089|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	24.4	804	902	1024	1.00e-61	226
k141_232407_6	NCBI|WP_000163435.1|1|1|mupA|mupA|insensitivity|2|mupirocin|mupirocin|mupirocin-resistant_isoleucine--tRNA_ligase_MupA|AMR|mupirocin	24.3	804	902	1024	1.82e-61	225
k141_232407_6	megares|MEG_4090|Drugs|Mupirocin|Mupirocin-resistant_isoleucyl-tRNA_synthetase|MUPA_1	24.4	804	902	1024	1.82e-61	225
k141_232407_6	SARG|gb|CAA53189|ARO:3000521|mupA	24.3	804	902	1024	3.29e-61	224
k141_232407_14	SARG|gb|CAE00499.1|ARO:3003835|cdeA	26.8	426	435	441	3.64e-55	188
k141_232407_22	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	32.0	125	277	228	1.60e-09	55.8
k141_232407_22	CARD|gb|ATC67679.1|ARO:3000838|arlR	30.3	122	277	219	2.68e-09	55.1
k141_232407_22	megares|MEG_4290|Drugs|beta-lactam|Mutant_porin_proteins|OMPR_1	29.8	121	277	252	6.15e-06	45.4
k141_108651_13	SARG|YP_302230	27.6	123	140	451	2.54e-07	47.4
k141_108651_14	SARG|gb|CAE00499.1|ARO:3003835|cdeA	26.2	202	308	441	6.80e-10	58.5
k141_108651_24	SARG|AAV80410	26.0	666	695	651	7.00e-53	192
k141_108651_24	SARG|L42544.gene.p01	25.7	666	695	651	4.59e-52	190
k141_108651_24	SARG|ZP_02952732	25.3	668	695	652	2.69e-50	185
k141_108651_24	SARG|ZP_02632674	25.3	668	695	660	2.98e-50	185
k141_108651_24	SARG|YP_002850805	25.6	668	695	652	3.67e-50	184
k141_108651_24	SARG|L20800.gene.p01	25.1	668	695	652	3.67e-50	184
k141_108651_24	SARG|NP_348076	24.9	667	695	652	5.01e-50	184
k141_108651_24	SARG|gi|1004359922|gb|AMP42228.1|	25.8	663	695	639	1.12e-47	177
k141_108651_24	megares|MEG_7163|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	24.8	662	695	629	1.01e-45	171
k141_108651_24	ResF|tet(O/W)_5_AM889122_1	24.8	662	695	639	1.13e-45	171
k141_108651_33	megares|MEG_5148|Drugs|beta-lactam|Class_D_betalactamases|OXA_1	25.0	228	385	346	9.21e-10	58.5
k141_94106_2	SARG|gi|742378414|ref|WP_038857601.1|	34.6	107	967	647	6.11e-10	62.0
k141_94106_2	SARG|YP_001438541	39.0	77	967	647	3.17e-09	59.7
k141_94106_2	SARG|gi|938461734|ref|WP_054625806.1|	39.0	77	967	647	3.17e-09	59.7
k141_94106_2	SARG|gi|938460528|ref|WP_054624864.1|	39.0	77	967	647	3.17e-09	59.7
k141_94106_2	SARG|gi|1020141879|ref|WP_063264839.1|	39.0	77	967	647	3.17e-09	59.7
k141_94106_2	SARG|gi|696411918|ref|WP_032982657.1|	39.0	77	967	647	3.17e-09	59.7
k141_94106_2	SARG|gi|696402390|ref|WP_032974230.1|	39.0	77	967	647	3.17e-09	59.7
k141_94106_2	SARG|gi|504542119|ref|WP_014729221.1|	39.0	77	967	647	3.17e-09	59.7
k141_94106_2	SARG|gi|490522515|ref|WP_004387938.1|	39.0	77	967	647	3.17e-09	59.7
k141_94106_2	SARG|gi|495067432|ref|WP_007792257.1|	39.0	77	967	647	3.17e-09	59.7
k141_171196_9	SARG|ZP_04679156	21.1	374	441	451	1.71e-10	61.6
k141_171196_9	SARG|YP_302230	20.2	371	441	451	2.26e-10	61.2
k141_171196_9	SARG|gi|505177635|ref|WP_015364737.1|	20.1	374	441	451	3.82e-09	57.4
k141_78415_9	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	29.7	691	664	703	2.85e-79	265
k141_78415_11	megares|MEG_6058|Drugs|MLS|23S_rRNA_methyltransferases|RLMH_1	42.4	158	162	159	1.07e-36	123
k141_78415_14	megares|MEG_727|Drugs|beta-lactam|Class_C_betalactamases|AMPC_1	40.7	408	414	415	8.78e-96	292
k141_78415_23	ResF|mre(A)_1_U92073_1	27.5	276	314	310	5.12e-24	98.6
k141_78415_23	SARG|gb|AAB64408.1|ARO:3007050|mreA	27.5	276	314	311	5.20e-24	98.6
k141_1731_4	SARG|gi|803568669|ref|WP_046077412.1|	43.6	225	235	648	2.84e-52	177
k141_1731_4	SARG|gi|446110352|ref|WP_000188207.1|	43.6	225	235	648	2.84e-52	177
k141_1731_4	SARG|YP_002382193	43.6	225	235	648	2.84e-52	177
k141_1731_4	SARG|gi|803575554|ref|WP_046081557.1|	43.6	225	235	648	2.84e-52	177
k141_1731_4	SARG|gi|446110351|ref|WP_000188206.1|	43.6	225	235	648	2.84e-52	177
k141_1731_4	SARG|gb|AAV85982.1|ARO:3000535|macB	39.1	233	235	644	1.01e-50	173
k141_1731_4	SARG|gi|1035670474|ref|WP_064517458.1|	41.0	229	235	648	1.46e-50	173
k141_1731_4	SARG|gi|502669352|ref|WP_012905216.1|	41.2	233	235	648	2.03e-50	172
k141_1731_4	SARG|gi|1035717981|ref|WP_064557480.1|	41.6	226	235	648	2.03e-50	172
k141_1731_4	SARG|gi|1035706844|ref|WP_064548272.1|	40.2	239	235	648	2.03e-50	172
k141_125813_28	SARG|Q47746	36.8	185	310	268	7.07e-34	124
k141_125813_28	SARG|gi|452996213|gb|AGG19398.1|	36.2	185	310	268	2.71e-33	122
k141_125813_28	SARG|gi|498515090|ref|WP_010815297.1|	36.2	185	310	268	2.71e-33	122
k141_125813_28	SARG|gi|403023847|gb|EJY36064.1|	34.6	185	310	200	2.05e-32	118
k141_125813_28	SARG|gi|403219412|emb|CCJ27774.1|	35.3	184	310	268	3.95e-32	119
k141_125813_28	SARG|gi|452996227|gb|AGG19410.1|	34.6	185	310	252	7.48e-32	118
k141_125813_28	SARG|gi|488259314|ref|WP_002330522.1|	34.6	185	310	268	1.08e-31	118
k141_125813_28	SARG|gi|1036536100|emb|SAM71699.1|	34.6	185	310	268	1.08e-31	118
k141_125813_28	SARG|KF823969.1.gene3.p01	34.6	185	310	268	1.08e-31	118
k141_125813_28	NCBI|WP_003126779.1|1|1|vanXY-C|vanXY-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-Ala-D-Ala_dipeptidase/D-Ala-D-Ala_carboxypeptidase_VanXY-C|AMR|glycopeptide	36.6	134	310	190	1.52e-17	78.2
k141_233932_8	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	41.7	693	665	703	3.93e-166	491
k141_126237_6	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	40.8	395	380	703	5.54e-83	266
k141_18223_12	CARD|gb|ATC67679.1|ARO:3000838|arlR	29.7	128	237	219	2.70e-06	45.8
k141_18223_16	NCBI|WP_002389535.1|1|1|bcrA_Lm|bcrA_Lm||2|peptide|peptide|peptide_resistance_ABC_transporter_ATP-binding_subunit_BcrA|AMR|peptide	27.2	217	237	307	1.65e-15	73.2
k141_172858_2	NCBI|WP_014936356.1|1|1|tva(B)|tva(B)|target_protection|2|TIAMULIN|PLEUROMUTILIN|ABC-F_type_ribosomal_protection_protein_Tva(B)|AMR|pleuromutilin	28.2	206	575	504	1.52e-12	68.9
k141_172858_2	SARG|gb|SOX29786.1|ARO:3004730|tva(A)	26.7	210	575	505	3.53e-12	67.8
k141_172858_27	SARG|gb|ADO96486.1|ARO:3003953|hmrM	24.0	217	473	464	3.71e-11	63.9
k141_172858_27	NCBI|AAC23256.1|1|1|hmrM|hmrM|efflux|1|EFFLUX|EFFLUX|sodium-coupled_multidrug_efflux_MATE_transporter_HmrM|AMR|efflux	24.0	217	473	464	3.71e-11	63.9
k141_65203_16	NCBI|WP_005480402.1|1|1|tet(35)|tet(35)|efflux|2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_Na+/H+_antiporter_family_transporter_Tet(35)|AMR|tetracycline	38.5	496	554	533	1.01e-95	300
k141_65203_16	SARG|AF353562.gene.p01	35.6	337	554	369	6.86e-52	180
k141_204460_8	SARG|gb|ADO96486.1|ARO:3003953|hmrM	22.2	451	459	464	1.82e-09	58.5
k141_204460_8	NCBI|AAC23256.1|1|1|hmrM|hmrM|efflux|1|EFFLUX|EFFLUX|sodium-coupled_multidrug_efflux_MATE_transporter_HmrM|AMR|efflux	22.2	451	459	464	2.41e-09	58.2
k141_235863_3	CARD|gb|AAC75429.1|ARO:3000833|evgS	28.6	420	1072	1197	3.17e-35	144
k141_235863_3	NCBI|WP_222891058.1|1|1|vanS-P|vanS-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-P|AMR|glycopeptide	25.9	224	1072	359	3.44e-17	83.6
k141_235863_3	CARD|gb|AAD51347.1|ARO:3003067|smeS	29.6	230	1072	467	1.08e-16	83.2
k141_142971_20	SARG|gb|APB03216.1|ARO:3003982|LlmA	55.7	291	293	287	8.19e-129	367
k141_142971_21	SARG|gi|671541568|ref|WP_031525212.1|	34.1	229	280	648	7.55e-29	114
k141_142971_21	SARG|gi|446048013|ref|WP_000125868.1|	32.9	207	280	648	3.93e-25	103
k141_142971_21	NCBI|WP_011116970.1|1|1|tetAB_B|tetAB_B|efflux|2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_TetAB_subunit_B|AMR|tetracycline	26.6	214	280	528	6.44e-13	67.4
k141_142971_21	SARG|gb|SOX29786.1|ARO:3004730|tva(A)	29.0	193	280	505	2.35e-09	56.6
k141_142971_21	megares|MEG_4306|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	22.8	206	280	655	6.37e-08	52.4
k141_142971_21	NCBI|WP_014936356.1|1|1|tva(B)|tva(B)|target_protection|2|TIAMULIN|PLEUROMUTILIN|ABC-F_type_ribosomal_protection_protein_Tva(B)|AMR|pleuromutilin	28.2	195	280	504	1.03e-07	51.6
k141_142971_21	megares|MEG_4313|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	22.8	206	280	655	1.51e-07	51.2
k141_142971_21	megares|MEG_4307|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	23.3	206	280	655	1.51e-07	51.2
k141_142971_21	megares|MEG_4321|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	22.8	206	280	655	1.51e-07	51.2
k141_142971_21	megares|MEG_4318|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|OPTRA_1	22.8	206	280	655	1.51e-07	51.2
k141_142971_22	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	33.6	226	307	255	1.18e-35	128
k141_142971_22	SARG|gb|AAK76137.1|ARO:3000024|patA	32.2	205	307	564	2.44e-20	90.1
k141_142971_22	SARG|gi|585358510|ref|WP_024240108.1|	29.0	214	307	648	1.04e-17	82.4
k141_142971_22	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	27.9	251	307	579	1.32e-17	82.0
k141_142971_22	SARG|gi|948137056|ref|WP_056795395.1|	27.4	230	307	602	2.19e-14	72.4
k141_142971_22	SARG|gb|APB03219.1|ARO:3003986|TaeA	24.6	252	307	648	2.38e-13	69.3
k141_142971_22	SARG|gi|517381192|ref|WP_018555350.1|	26.5	219	307	602	2.39e-12	66.2
k141_97716_4	SARG|gb|AAV85982.1|ARO:3000535|macB	34.6	413	401	644	8.20e-54	187
k141_97716_4	SARG|gi|1001720867|ref|WP_061274204.1|	34.4	410	401	648	3.88e-49	175
k141_97716_4	SARG|gi|495736522|ref|WP_008461101.1|	34.4	410	401	648	5.35e-49	174
k141_97716_4	SARG|gi|746253210|ref|WP_039301529.1|	34.4	410	401	648	5.35e-49	174
k141_97716_4	SARG|gi|746243059|ref|WP_039291473.1|	34.4	410	401	648	7.39e-49	174
k141_97716_4	SARG|gi|554689873|ref|WP_023186409.1|	34.2	407	401	648	5.11e-48	172
k141_97716_4	SARG|gi|489039527|ref|WP_002949857.1|	34.2	407	401	648	5.11e-48	172
k141_97716_4	SARG|gi|446048047|ref|WP_000125902.1|	34.2	407	401	648	5.11e-48	172
k141_97716_4	SARG|gi|554685678|ref|WP_023185565.1|	34.1	408	401	648	2.55e-47	170
k141_97716_4	SARG|gi|487407385|ref|WP_001675419.1|	33.9	407	401	648	3.51e-47	169
k141_97716_5	SARG|gi|851928815|ref|WP_048221086.1|	53.1	241	252	648	9.27e-83	259
k141_97716_5	SARG|gi|780033092|ref|WP_045444768.1|	53.1	241	252	648	9.27e-83	259
k141_97716_5	SARG|gi|757799695|ref|WP_043016897.1|	53.5	241	252	648	1.30e-82	258
k141_97716_5	SARG|gi|922960663|ref|WP_053388845.1|	53.1	241	252	648	3.62e-82	257
k141_97716_5	SARG|gi|1045891604|ref|WP_065554100.1|	53.1	241	252	648	5.08e-82	257
k141_97716_5	SARG|gi|507082903|ref|WP_016153652.1|	53.1	241	252	648	5.08e-82	257
k141_97716_5	SARG|gi|507086196|ref|WP_016156937.1|	53.1	241	252	648	5.08e-82	257
k141_97716_5	SARG|gi|639225329|ref|WP_024561799.1|	54.3	232	252	648	2.78e-81	255
k141_97716_5	SARG|gi|639218559|ref|WP_024556062.1|	54.3	232	252	648	2.78e-81	255
k141_97716_5	SARG|gi|919601241|ref|WP_052893936.1|	57.1	224	252	648	5.50e-81	254
k141_205198_11	SARG|NP_348076	26.1	452	525	652	1.87e-38	148
k141_205198_11	SARG|YP_002850805	27.5	459	525	652	6.33e-38	146
k141_205198_11	SARG|ZP_02952732	27.2	460	525	652	2.43e-36	142
k141_205198_11	SARG|L20800.gene.p01	27.2	460	525	652	2.43e-36	142
k141_205198_11	SARG|ZP_02632674	27.2	460	525	660	2.55e-36	142
k141_205198_11	SARG|CAA37477	32.1	312	525	663	4.67e-33	132
k141_205198_11	SARG|Q08425	25.4	464	525	641	1.11e-31	128
k141_205198_11	NCBI|WP_063856408.1|1|1|tet(Q)|tet(Q)|target_protection|2|TETRACYCLINE|TETRACYCLINE|tetracycline_resistance_ribosomal_protection_protein_Tet(Q)|AMR|tetracycline	25.4	464	525	654	1.18e-31	128
k141_205198_11	megares|MEG_7181|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETQ_1	25.4	464	525	657	1.19e-31	128
k141_205198_11	SARG|Z21523.gene.p01	25.4	464	525	657	1.19e-31	128
k141_5198_5	SARG|gb|ANZ79240.1|ARO:3004035|tetA(60)	32.0	516	594	579	9.38e-81	264
k141_5198_5	NCBI|WP_289811734.1|1|1|tetA(60)|tetA(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_A|AMR|tetracycline	32.0	516	594	579	3.60e-80	262
k141_5198_5	SARG|gb|WP_104671188.1|ARO:3003948|efrA	31.9	527	594	575	1.75e-79	260
k141_5198_5	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	31.2	519	594	574	7.45e-76	251
k141_5198_5	SARG|gb|AAK76137.1|ARO:3000024|patA	32.3	493	594	564	2.51e-72	241
k141_5198_5	SARG|gb|AAC74000.1|ARO:3003950|msbA	28.2	531	594	582	2.88e-69	233
k141_5198_5	SARG|gi|1045390184|ref|WP_065479071.1|	29.0	487	594	605	1.29e-65	224
k141_5198_5	SARG|gi|664556405|ref|WP_031071225.1|	29.0	487	594	602	4.52e-65	223
k141_5198_5	SARG|gi|928900436|ref|WP_053931243.1|	28.5	526	594	600	1.17e-64	221
k141_5198_5	SARG|gi|664579989|ref|WP_031094015.1|	28.5	526	594	601	1.19e-64	221
k141_5198_6	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	33.4	584	628	579	3.95e-98	310
k141_5198_6	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	33.9	584	628	579	4.58e-96	305
k141_5198_6	SARG|gb|AET10445.1|ARO:3004033|tetB(46)	34.2	515	628	578	6.36e-85	276
k141_5198_6	SARG|gi|928900436|ref|WP_053931243.1|	31.1	578	628	600	1.96e-78	259
k141_5198_6	SARG|gi|664579989|ref|WP_031094015.1|	31.1	578	628	601	2.00e-78	259
k141_5198_6	SARG|gi|496018010|ref|WP_008742581.1|	31.0	578	628	623	6.41e-78	258
k141_5198_6	SARG|gb|WP_104671188.1|ARO:3003948|efrA	32.7	504	628	575	1.14e-77	256
k141_5198_6	SARG|gi|764446018|ref|WP_044369325.1|	30.8	581	628	605	1.16e-77	257
k141_5198_6	SARG|gi|497748188|ref|WP_010062372.1|	30.8	581	628	605	2.27e-77	256
k141_5198_6	SARG|gi|948137056|ref|WP_056795395.1|	30.9	580	628	602	2.96e-77	256
k141_5823_8	SARG|gi|1035717981|ref|WP_064557480.1|	36.7	248	272	648	5.06e-42	151
k141_5823_8	SARG|gi|803568669|ref|WP_046077412.1|	36.3	248	272	648	6.97e-42	150
k141_5823_8	SARG|gi|446110352|ref|WP_000188207.1|	36.3	248	272	648	6.97e-42	150
k141_5823_8	SARG|YP_002382193	36.3	248	272	648	6.97e-42	150
k141_5823_8	SARG|gi|803575554|ref|WP_046081557.1|	36.3	248	272	648	6.97e-42	150
k141_5823_8	SARG|gi|823291602|ref|WP_047047573.1|	37.7	247	272	648	6.97e-42	150
k141_5823_8	SARG|gi|446110351|ref|WP_000188206.1|	36.3	248	272	648	6.97e-42	150
k141_5823_8	SARG|gi|736472622|ref|WP_034494292.1|	36.7	248	272	648	6.97e-42	150
k141_5823_8	SARG|gi|1035706844|ref|WP_064548272.1|	37.5	248	272	648	9.60e-42	150
k141_5823_8	SARG|gi|896325272|ref|WP_049294291.1|	37.2	253	272	648	9.60e-42	150
k141_206557_14	SARG|gi|671541568|ref|WP_031525212.1|	31.6	237	366	648	1.75e-18	85.9
k141_206557_14	SARG|Q83LR7	31.6	234	366	648	2.35e-18	85.5
k141_206557_14	SARG|gi|647325472|ref|WP_025760953.1|	31.6	234	366	648	2.35e-18	85.5
k141_206557_14	SARG|gi|647323678|ref|WP_025760497.1|	31.6	234	366	648	2.35e-18	85.5
k141_206557_14	SARG|gi|766974935|ref|WP_044866868.1|	30.5	249	366	648	3.15e-18	85.1
k141_206557_14	SARG|gi|510923671|ref|WP_016244456.1|	31.6	234	366	648	3.15e-18	85.1
k141_206557_14	SARG|gi|754732608|ref|WP_042101370.1|	30.8	237	366	648	3.15e-18	85.1
k141_206557_14	SARG|gi|446110297|ref|WP_000188152.1|	30.8	237	366	648	3.15e-18	85.1
k141_206557_14	SARG|gi|545248218|ref|WP_021546584.1|	31.6	253	366	648	3.15e-18	85.1
k141_206557_14	SARG|gi|742907943|ref|WP_039020462.1|	29.9	234	366	648	3.15e-18	85.1
k141_68121_9	NCBI|WP_063856700.1|1|1|vanH-Ao2|vanH-Ao2|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ao2|AMR|glycopeptide	27.9	215	387	343	1.29e-15	76.3
k141_68121_9	NCBI|WP_063856699.1|1|1|vanH-Ao1|vanH-Ao1|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Ao1|AMR|glycopeptide	27.9	215	387	348	1.34e-15	76.3
k141_68121_9	SARG|YP_002333394	36.3	124	387	323	4.86e-15	74.3
k141_68121_9	SARG|AF310956.2.gene5.p01	35.5	124	387	323	1.60e-14	72.8
k141_68121_9	NCBI|WP_063856701.1|1|1|vanH-B|vanH-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-B|AMR|glycopeptide	35.5	124	387	323	1.60e-14	72.8
k141_68121_9	NCBI|WP_011029109.1|1|1|vanH-Sc|vanH-Sc|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-Sc|AMR|glycopeptide	27.6	232	387	337	3.24e-14	72.0
k141_68121_9	SARG|AAY52004	30.0	217	387	322	5.22e-14	71.2
k141_68121_9	SARG|gi|746609237|ref|WP_039635344.1|	29.4	201	387	322	7.02e-14	70.9
k141_68121_9	SARG|gi|749574782|ref|WP_040203616.1|	28.8	229	387	323	9.52e-14	70.5
k141_68121_9	megares|MEG_7399|Drugs|Glycopeptide|VanA-type_resistance_protein|VANHA_1	32.4	136	387	237	2.28e-13	68.2
k141_68121_19	SARG|AF310956.2.gene5.p01	37.8	156	335	323	2.69e-18	83.2
k141_68121_19	NCBI|WP_063856701.1|1|1|vanH-B|vanH-B|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|D-lactate_dehydrogenase_VanH-B|AMR|glycopeptide	37.8	156	335	323	2.69e-18	83.2
k141_68121_19	SARG|AAF72362	37.2	156	335	323	1.26e-17	81.3
k141_68121_19	SARG|YP_002333394	37.2	156	335	323	1.72e-17	80.9
k141_68121_19	SARG|Q47748	36.5	156	335	323	7.98e-17	79.0
k141_68121_19	SARG|gb|AAB05626.1|ARO:3002943|vanHB	36.5	156	335	323	1.08e-16	78.6
k141_68121_19	SARG|gi|498515089|ref|WP_010815296.1|	36.5	156	335	323	2.00e-16	77.8
k141_68121_19	SARG|gi|985522333|ref|WP_060811962.1|	36.5	156	335	323	2.00e-16	77.8
k141_68121_19	SARG|AAR37059	30.3	185	335	323	1.00e-11	63.9
k141_68121_19	SARG|AAD51059	29.7	185	335	323	3.26e-11	62.4
k141_207283_9	SARG|HE999704.1.gene3064.p01	34.8	204	458	241	2.21e-33	125
k141_207283_9	SARG|gi|505177635|ref|WP_015364737.1|	23.0	439	458	451	6.76e-33	128
k141_207283_9	SARG|ZP_04679156	23.2	439	458	451	1.27e-32	127
k141_207283_9	SARG|gi|441475675|emb|CCQ25429.1|	38.7	137	458	211	2.54e-24	99.4
k141_116637_19	SARG|ZP_04081918	28.6	241	514	306	1.44e-13	70.5
k141_116637_19	SARG|gi|507055561|ref|WP_016126482.1|	26.6	233	514	309	2.00e-13	70.1
k141_116637_19	SARG|P42332	28.4	225	514	306	2.60e-13	69.7
k141_116637_19	SARG|ABB80128	28.4	225	514	306	2.60e-13	69.7
k141_116637_19	megares|MEG_1213|Drugs|Bacitracin|Bacitracin_ABC_transporter|BCRA_1	28.4	225	514	306	2.60e-13	69.7
k141_116637_19	SARG|gi|510143239|gb|AGN36970.1|	28.4	225	514	313	2.78e-13	69.7
k141_116637_19	SARG|gi|542061059|gb|ERI11611.1|	25.5	259	514	316	2.86e-13	69.7
k141_116637_19	SARG|gi|488120365|ref|WP_002191762.1|	27.5	233	514	309	4.81e-13	68.9
k141_116637_19	SARG|gi|488068784|ref|WP_002140181.1|	27.0	233	514	309	4.81e-13	68.9
k141_116637_19	SARG|gi|447195835|ref|WP_001273091.1|	27.8	241	514	306	6.28e-13	68.6
k141_133117_20	SARG|YP_002929946	55.6	279	277	282	8.84e-99	290
k141_133117_20	SARG|ZP_04528247	57.4	272	277	279	8.62e-96	282
k141_133117_20	SARG|YP_002937728	54.4	281	277	289	2.96e-91	271
k141_133117_20	SARG|ZP_03984017	52.2	270	277	288	3.29e-90	268
k141_133117_20	SARG|ZP_04433866	52.2	270	277	288	6.61e-90	267
k141_133117_20	SARG|ZP_03949893	51.9	270	277	288	2.67e-89	266
k141_133117_20	SARG|ZP_03945515	52.2	274	277	291	1.68e-88	264
k141_133117_20	SARG|ZP_03941859	53.7	268	277	288	4.97e-87	260
k141_133117_20	SARG|ZP_03938934	53.7	268	277	288	4.97e-87	260
k141_133117_20	SARG|ZP_03958019	51.8	282	277	317	1.31e-83	252
k141_133117_28	SARG|YP_302230	23.7	257	453	451	4.02e-09	57.4
k141_133117_28	SARG|gi|505177635|ref|WP_015364737.1|	23.4	256	453	451	1.65e-08	55.5
k141_133117_35	SARG|gb|CAE00499.1|ARO:3003835|cdeA	35.0	431	451	441	6.13e-92	284
k141_209772_5	NCBI|XSG12260.1|1|1|drcA|drcA||1|||daptomycin_efflux_ABC_transporter_ATP-binding_protein_DrcA|AMR|peptide	36.1	205	255	255	8.70e-43	145
k141_209772_5	SARG|gi|694064328|ref|WP_032410816.1|	32.4	225	255	646	1.39e-33	127
k141_209772_5	SARG|gb|CDO61516.1|ARO:3003949|efrB	31.0	200	255	362	9.74e-22	91.7
k141_209772_5	SARG|gb|WP_104671188.1|ARO:3003948|efrA	28.1	224	255	575	2.53e-21	91.7
k141_209772_5	SARG|gb|AAK76137.1|ARO:3000024|patA	25.3	221	255	564	2.38e-19	85.9
k141_209772_5	SARG|gi|493394434|ref|WP_006350564.1|	29.3	222	255	602	3.34e-19	85.5
k141_209772_5	SARG|gi|926286457|ref|WP_053623344.1|	30.2	222	255	605	6.12e-19	84.7
k141_209772_5	SARG|gi|648667297|ref|WP_026359044.1|	30.8	221	255	605	8.29e-19	84.3
k141_209772_5	SARG|gi|662175949|ref|WP_030118884.1|	30.2	222	255	605	1.12e-18	84.0
k141_209772_5	SARG|gi|663155409|ref|WP_030194633.1|	30.2	222	255	605	1.12e-18	84.0
k141_209772_10	SARG|AAA22075	31.9	204	286	340	1.62e-14	71.6
k141_209772_10	SARG|gb|OPG86592.1|ARO:3004626|Erm(49)	28.4	197	286	304	1.37e-11	62.8
k141_209772_10	SARG|L22689.1.gene1.p01	30.6	157	286	257	1.09e-10	59.7
k141_103087_14	SARG|gi|446048013|ref|WP_000125868.1|	27.4	223	512	648	3.04e-22	99.4
k141_103087_14	SARG|gb|AAC75271.1|ARO:3003952|yojI	31.8	198	512	547	2.69e-15	77.4
k141_103087_14	SARG|gi|1005616587|ref|WP_061695226.1|	24.6	252	512	648	2.13e-13	71.6
k141_103087_14	SARG|gi|923061916|ref|WP_053445667.1|	24.6	252	512	648	2.13e-13	71.6
k141_103087_14	SARG|gi|922019548|ref|WP_053299973.1|	24.6	252	512	648	2.82e-13	71.2
k141_103087_14	SARG|gb|AYV52072.1|ARO:3002882|lmrD	27.7	213	512	664	2.87e-13	71.2
k141_103087_14	SARG|gi|555271393|ref|WP_023251561.1|	24.2	252	512	648	4.93e-13	70.5
k141_103087_14	SARG|gi|555246906|ref|WP_023230855.1|	24.2	252	512	648	6.52e-13	70.1
k141_103087_14	SARG|gi|446048045|ref|WP_000125900.1|	24.2	252	512	648	6.52e-13	70.1
k141_103087_14	SARG|gi|555241715|ref|WP_023226297.1|	24.2	252	512	648	6.52e-13	70.1
k141_165102_8	SARG|gi|896325272|ref|WP_049294291.1|	40.0	245	261	648	1.53e-44	157
k141_165102_8	SARG|gi|968563772|ref|WP_058587854.1|	39.1	243	261	648	7.66e-44	155
k141_165102_8	SARG|gi|639216333|ref|WP_024554080.1|	39.6	245	261	648	7.66e-44	155
k141_165102_8	SARG|gi|639225329|ref|WP_024561799.1|	41.4	249	261	648	1.06e-43	155
k141_165102_8	SARG|gi|639218559|ref|WP_024556062.1|	41.4	249	261	648	1.06e-43	155
k141_165102_8	SARG|gi|992390012|ref|WP_061077002.1|	39.1	243	261	648	1.46e-43	155
k141_165102_8	SARG|gi|494938585|ref|WP_007664615.1|	40.8	245	261	647	2.00e-43	154
k141_165102_8	SARG|gi|754964360|ref|WP_042320280.1|	38.8	245	261	648	2.01e-43	154
k141_165102_8	SARG|gi|757782629|ref|WP_043001213.1|	38.7	243	261	648	3.83e-43	154
k141_165102_8	SARG|gi|763407609|ref|WP_044264203.1|	38.7	243	261	648	3.83e-43	154
k141_103804_5	SARG|gb|AAA26793|ARO:3003748|oleC	28.6	213	238	325	1.45e-19	84.7
k141_103804_5	megares|MEG_4276|Drugs|MLS|MLS_resistance_ABC_efflux_pumps|OLEC_1	28.6	213	238	325	1.45e-19	84.7
k141_103804_5	SARG|gb|AAK76137.1|ARO:3000024|patA	27.4	219	238	564	1.29e-16	77.4
k141_103804_6	SARG|gb|APB03214.1|ARO:3003980|tetA(48)	31.1	238	280	343	8.89e-29	111
k141_103804_6	SARG|gb|AAC75271.1|ARO:3003952|yojI	29.1	196	280	547	9.52e-16	75.9
k141_103804_18	SARG|gb|WP_104671188.1|ARO:3003948|efrA	36.4	544	584	575	3.94e-110	340
k141_103804_18	SARG|gb|AAK76137.1|ARO:3000024|patA	35.7	568	584	564	2.72e-107	332
k141_103804_18	SARG|gb|AYV52072.1|ARO:3002882|lmrD	30.4	500	584	664	5.86e-64	221
k141_103804_18	SARG|gi|695865802|ref|WP_032778631.1|	29.0	566	584	605	1.03e-63	219
k141_103804_18	SARG|gi|662175949|ref|WP_030118884.1|	29.7	566	584	605	1.03e-63	219
k141_103804_18	SARG|gi|497748188|ref|WP_010062372.1|	28.8	566	584	605	1.43e-63	218
k141_103804_18	SARG|gi|764446018|ref|WP_044369325.1|	29.2	566	584	605	1.43e-63	218
k141_103804_18	SARG|gi|663330365|ref|WP_030329892.1|	29.7	566	584	607	1.49e-63	218
k141_103804_18	SARG|gi|664180077|ref|WP_030714054.1|	29.0	566	584	605	1.99e-63	218
k141_103804_18	SARG|gi|517787730|ref|WP_018957938.1|	29.3	566	584	610	3.04e-63	218
k141_103804_19	SARG|gb|AAK76136.1|ARO:3000025|patB	33.3	610	641	588	6.86e-103	323
k141_103804_19	SARG|gb|AYV52072.1|ARO:3002882|lmrD	35.5	518	641	664	2.03e-95	306
k141_103804_19	SARG|gi|944009777|ref|WP_055601444.1|	31.3	633	641	628	3.57e-87	283
k141_103804_19	SARG|gi|493394434|ref|WP_006350564.1|	31.0	625	641	602	5.22e-87	282
k141_103804_19	SARG|gi|497748188|ref|WP_010062372.1|	31.3	610	641	605	7.86e-87	282
k141_103804_19	SARG|gi|695887424|ref|WP_032788534.1|	31.0	620	641	605	1.54e-86	281
k141_103804_19	SARG|gi|817122037|ref|WP_046494699.1|	32.2	631	641	613	1.87e-86	281
k141_103804_19	SARG|gi|664180077|ref|WP_030714054.1|	31.3	624	641	605	2.16e-86	281
k141_103804_19	SARG|gi|764446018|ref|WP_044369325.1|	30.8	620	641	605	5.90e-86	280
k141_103804_19	SARG|gi|695865802|ref|WP_032778631.1|	31.1	610	641	605	8.26e-86	279
k141_103804_25	megares|MEG_7572|Drugs|Glycopeptide|VanM-type_resistance_protein|VANXM_2	38.6	440	457	481	2.01e-89	279
k141_103804_25	megares|MEG_7571|Drugs|Glycopeptide|VanM-type_resistance_protein|VANXM_2	37.7	440	457	451	1.49e-87	273
k141_103804_25	megares|MEG_7563|Drugs|Glycopeptide|VanB-type_resistance_protein|VANXB_2	39.1	430	457	451	2.09e-87	273
k141_103804_26	ResF|penA_1_AF515059_1	24.1	377	832	581	5.30e-23	103
k141_242742_9	CARD|gb|CYF42523.1|ARO:3004047|kdpD	25.7	284	359	885	5.48e-28	114
k141_242742_10	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	43.0	221	241	225	1.01e-59	187
k141_242742_10	CARD|gb|AAC73788.1|ARO:3003841|kdpE	43.0	221	241	225	1.01e-59	187
k141_242742_10	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	35.1	225	241	229	1.77e-44	148
k141_242742_10	NCBI|WP_222891057.1|1|1|vanR-P|vanR-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-P|AMR|glycopeptide	35.1	239	241	239	1.46e-42	143
k141_242742_10	NCBI|WP_063856728.1|1|1|vanR-N|vanR-N|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-N|AMR|glycopeptide	33.2	223	241	230	4.52e-42	142
k141_242742_10	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	35.0	226	241	232	1.06e-40	138
k141_242742_10	NCBI|WP_063856724.1|1|1|vanR-L|vanR-L|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-L|AMR|glycopeptide	33.9	224	241	231	1.14e-39	135
k141_242742_10	NCBI|WP_063856721.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	34.1	226	241	231	1.26e-38	133
k141_242742_10	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	34.9	232	241	231	1.26e-38	133
k141_242742_10	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	34.5	226	241	231	1.77e-38	132
k141_88214_5	ResF|penA_1_AF515059_1	25.7	604	621	581	1.74e-51	186
k141_88214_5	megares|MEG_5400|Drugs|beta-lactam|Penicillin_binding_protein|PBP2_1	24.2	520	621	633	6.41e-30	124
k141_88214_5	NCBI|WP_049151672.1|1|1|pbp2m|pbp2m||2|beta-lactam|beta-lactam|penicillin-binding_protein_PBP2M|AMR|beta-lactam	23.5	336	621	593	3.29e-11	65.1
k141_88214_7	CARD|gb|AAN28945.1|ARO:3003785|Ctra_murA_FOF	32.5	437	450	444	4.40e-40	148
k141_88214_21	SARG|Q83LR7	40.3	236	255	648	1.36e-46	163
k141_88214_21	SARG|gi|647325472|ref|WP_025760953.1|	40.3	236	255	648	1.36e-46	163
k141_88214_21	SARG|gi|647323678|ref|WP_025760497.1|	40.3	236	255	648	1.36e-46	163
k141_88214_21	SARG|gi|446110301|ref|WP_000188156.1|	40.7	236	255	648	1.88e-46	162
k141_88214_21	SARG|gi|693106883|ref|WP_032260279.1|	40.7	236	255	648	3.60e-46	162
k141_88214_21	SARG|gi|643601187|ref|WP_025237288.1|	40.3	236	255	648	4.98e-46	161
k141_88214_21	SARG|gi|545167026|ref|WP_021521592.1|	40.3	236	255	648	4.98e-46	161
k141_88214_21	SARG|gi|974628291|ref|WP_059215695.1|	40.3	236	255	648	4.98e-46	161
k141_88214_21	SARG|gi|446110298|ref|WP_000188153.1|	40.3	236	255	648	4.98e-46	161
k141_88214_21	SARG|gi|971845730|ref|WP_058914924.1|	40.7	236	255	648	4.98e-46	161
k141_88214_24	SARG|gb|WP_104671188.1|ARO:3003948|efrA	37.5	547	580	575	7.63e-116	355
k141_88214_24	SARG|gb|AAK76137.1|ARO:3000024|patA	35.5	512	580	564	2.28e-96	304
k141_88214_24	SARG|gb|AAC74000.1|ARO:3003950|msbA	28.0	567	580	582	8.39e-64	218
k141_88214_24	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	28.4	582	580	579	1.45e-57	201
k141_88214_24	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	27.1	583	580	579	1.95e-56	198
k141_88214_24	NCBI|WP_289811734.1|1|1|tetA(60)|tetA(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_A|AMR|tetracycline	30.0	466	580	579	1.32e-54	193
k141_88214_24	SARG|gb|ANZ79240.1|ARO:3004035|tetA(60)	28.7	464	580	579	1.32e-54	193
k141_88214_24	SARG|gb|AYV52072.1|ARO:3002882|lmrD	27.0	500	580	664	1.20e-52	189
k141_88214_24	SARG|gb|AET10444.1|ARO:3004032|tetA(46)	32.1	383	580	574	5.60e-52	186
k141_88214_24	SARG|gb|AET10445.1|ARO:3004033|tetB(46)	29.0	493	580	578	5.98e-52	186
k141_88214_25	SARG|gb|AAK76136.1|ARO:3000025|patB	34.7	576	592	588	2.58e-110	341
k141_88214_25	SARG|gb|AYV52072.1|ARO:3002882|lmrD	37.0	519	592	664	3.03e-104	328
k141_88214_25	SARG|gb|CDO61516.1|ARO:3003949|efrB	46.2	333	592	362	2.72e-93	290
k141_88214_25	SARG|gi|860594225|ref|WP_048475168.1|	32.8	597	592	620	6.30e-87	281
k141_88214_25	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	32.7	575	592	579	1.25e-86	279
k141_88214_25	SARG|gi|944152509|ref|WP_055644808.1|	33.0	575	592	616	6.05e-86	278
k141_88214_25	SARG|gi|772774655|ref|WP_045322518.1|	32.9	584	592	620	6.65e-86	278
k141_88214_25	SARG|gi|496018010|ref|WP_008742581.1|	33.1	601	592	623	7.14e-86	278
k141_88214_25	SARG|gi|917127754|ref|WP_051734466.1|	32.7	584	592	620	9.32e-86	278
k141_88214_25	SARG|gi|928900436|ref|WP_053931243.1|	34.0	582	592	600	1.59e-85	277
k141_149126_5	SARG|gb|WP_104671188.1|ARO:3003948|efrA	23.3	507	577	575	7.61e-39	149
k141_149126_5	SARG|gb|AAK76137.1|ARO:3000024|patA	33.5	239	577	564	2.31e-38	147
k141_149126_5	SARG|gb|AYV52072.1|ARO:3002882|lmrD	23.9	493	577	664	4.37e-34	136
k141_149126_5	SARG|gb|CDO61516.1|ARO:3003949|efrB	29.9	231	577	362	9.18e-27	110
k141_149126_5	SARG|gb|SOX29786.1|ARO:3004730|tva(A)	27.5	193	577	505	9.52e-10	60.1
k141_149126_5	NCBI|WP_014936356.1|1|1|tva(B)|tva(B)|target_protection|2|TIAMULIN|PLEUROMUTILIN|ABC-F_type_ribosomal_protection_protein_Tva(B)|AMR|pleuromutilin	25.4	209	577	504	1.66e-09	59.3
k141_149126_5	NCBI|AJP12342.1|1|1|cplR|cplR|target_protection|1|CLINDAMYCIN/LINCOMYCIN/RETAPAMULIN/VIRGINIAMYCIN|LINCOSAMIDE/PLEUROMUTILIN/STREPTOGRAMIN|ABC-F_type_ribosomal_protection_protein_CplR|AMR|multidrug	24.1	216	577	550	3.16e-06	48.9
k141_149126_6	SARG|gb|AAK76136.1|ARO:3000025|patB	26.8	462	557	588	6.67e-44	163
k141_149126_6	SARG|gb|AYV52072.1|ARO:3002882|lmrD	26.8	470	557	664	3.35e-42	159
k141_149126_6	NCBI|WP_289811733.1|1|1|tetB(60)|tetB(60)||2|TETRACYCLINE|TETRACYCLINE|tetracycline_efflux_ABC_transporter_Tet(60)_subunit_B|AMR|tetracycline	28.3	492	557	579	1.81e-37	145
k141_149126_6	SARG|gb|AET10445.1|ARO:3004033|tetB(46)	26.6	545	557	578	4.50e-37	144
k141_149126_6	SARG|gb|ANZ79241.1|ARO:3004036|tetB(60)	28.8	545	557	579	3.86e-36	141
k141_149126_6	SARG|gb|WP_104671188.1|ARO:3003948|efrA	27.8	460	557	575	6.85e-36	140
k141_149126_6	SARG|gi|491465657|ref|WP_005323423.1|	31.3	150	557	513	1.70e-10	62.4
k141_149126_6	SARG|gi|171851258|emb|CAQ04234.1|	30.7	150	557	483	2.13e-10	62.0
k141_149126_6	SARG|gi|736993687|ref|WP_034989673.1|	31.3	150	557	513	2.98e-10	61.6
k141_149126_6	SARG|AF024666.2.gene6.p01	31.3	150	557	513	2.98e-10	61.6
k141_149126_12	SARG|gi|510923671|ref|WP_016244456.1|	31.5	241	351	648	1.71e-20	91.7
k141_149126_12	SARG|gi|693106883|ref|WP_032260279.1|	31.5	241	351	648	2.30e-20	91.3
k141_149126_12	SARG|gi|971845730|ref|WP_058914924.1|	32.0	241	351	648	2.30e-20	91.3
k141_149126_12	SARG|gi|486425021|ref|WP_001614493.1|	32.0	241	351	648	2.30e-20	91.3
k141_149126_12	SARG|YP_309843	31.5	241	351	648	3.09e-20	90.9
k141_149126_12	SARG|gi|898532714|ref|WP_049595067.1|	31.5	241	351	648	3.09e-20	90.9
k141_149126_12	SARG|NP_286651	32.0	241	351	648	3.09e-20	90.9
k141_149126_12	SARG|gi|754829466|ref|WP_042191851.1|	31.5	241	351	648	3.09e-20	90.9
k141_149126_12	SARG|gi|920465160|ref|WP_052991191.1|	31.5	241	351	648	3.09e-20	90.9
k141_149126_12	SARG|gi|391288090|gb|EIQ46599.1|	31.5	241	351	645	4.14e-20	90.5
k141_149126_20	SARG|gb|CDO61516.1|ARO:3003949|efrB	31.2	157	338	362	1.87e-14	72.4
k141_149126_26	SARG|gb|AAC75314.1|ARO:3003578|pmrF	26.1	314	326	322	2.36e-27	108
k141_149126_31	ResF|poxtA-Ef_1_WP094899500.1_1	24.2	186	193	538	2.74e-09	54.7
k141_149126_31	megares|MEG_8639|Drugs|Multi-drug_resistance|Multi-drug_ABC_efflux_pumps|POXT_1	24.2	186	193	543	2.74e-09	54.7
k141_149126_31	NCBI|WP_094899500.1|1|1|poxtA-Ef|poxtA-Ef|target_protection|2|CHLORAMPHENICOL/FLORFENICOL/LINEZOLID|OXAZOLIDINONE/PHENICOL|ABC-F_type_ribosomal_protection_protein_PoxtA-Ef|AMR|multidrug	24.2	186	193	543	2.74e-09	54.7
k141_166862_1	SARG|gi|1004359922|gb|AMP42228.1|	26.4	436	437	639	1.56e-27	114
k141_166862_1	SARG|ABN80187	25.5	435	437	640	2.25e-26	110
k141_166862_1	megares|MEG_7169|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	26.1	437	437	629	7.14e-26	109
k141_166862_1	megares|MEG_7170|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	26.1	437	437	629	7.14e-26	109
k141_166862_1	ResF|tet(O/W)_3_AM889120_1	26.1	437	437	639	7.30e-26	109
k141_166862_1	ResF|tet(O/W)_4_AM889121_1	26.1	437	437	639	7.30e-26	109
k141_166862_1	SARG|ABN79417	26.0	438	437	639	9.81e-26	108
k141_166862_1	SARG|AAO42740	26.0	438	437	639	9.81e-26	108
k141_166862_1	SARG|AY485126.gene.p01	26.0	438	437	639	9.81e-26	108
k141_166862_1	megares|MEG_7175|Drugs|Tetracycline|Tetracycline_resistance_ribosomal_protection_proteins|TETO_1	26.0	438	437	639	9.81e-26	108
k141_166862_2	SARG|gb|ABA71733.1|ARO:3002972|vanTG	34.6	376	400	712	4.05e-57	197
k141_166862_2	NCBI|CZR78671.1|1|1|vanT-Cd|vanT-Cd|re-structuring_of_the_cell_wall|1|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-Cd|AMR|glycopeptide	34.8	376	400	712	1.99e-55	193
k141_166862_2	NCBI|WP_063856752.1|1|1|vanT-G|vanT-G|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|membrane-bound_serine_racemase_VanT-G|AMR|glycopeptide	32.7	376	400	711	1.37e-48	174
k141_244065_2	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	34.8	224	225	231	1.95e-39	134
k141_244065_2	NCBI|WP_063856718.1|1|1|vanR-E|vanR-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-E|AMR|glycopeptide	34.2	225	225	229	7.32e-39	133
k141_244065_2	CARD|gb|AAC73788.1|ARO:3003841|kdpE	31.6	225	225	225	5.05e-31	112
k141_244065_2	megares|MEG_3448|Drugs|Aminoglycosides|Aminoglycoside_efflux_pumps|KDPE_1	31.1	225	225	225	1.97e-30	111
k141_72594_16	NCBI|WP_006285581.1|1|1|vanR-F|vanR-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-F|AMR|glycopeptide	46.7	229	232	231	4.32e-68	208
k141_72594_16	NCBI|WP_011461303.1|1|1|vanR-I|vanR-I|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-I|AMR|glycopeptide	44.1	227	232	232	7.05e-62	192
k141_72594_16	megares|MEG_7482|Drugs|Glycopeptide|VanL-type_regulator|VANRI_1	44.1	227	232	232	7.05e-62	192
k141_72594_16	CARD|gb|ATC67679.1|ARO:3000838|arlR	40.7	221	232	219	1.34e-61	191
k141_72594_16	megares|MEG_4078|Drugs|Multi-drug_resistance|Multi-drug_RND_efflux_regulator|MTRAD_1	42.4	224	232	228	1.01e-60	189
k141_72594_16	NCBI|WP_063856726.1|1|1|vanR-M|vanR-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-M|AMR|glycopeptide	41.3	230	232	232	1.61e-60	189
k141_72594_16	megares|MEG_7449|Drugs|Glycopeptide|VanA-type_regulator|VANRA_1	41.0	229	232	231	1.15e-57	181
k141_72594_16	NCBI|WP_063856716.1|1|1|vanR-A|vanR-A|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-A|AMR|glycopeptide	41.6	231	232	231	1.15e-57	181
k141_72594_16	NCBI|WP_005228837.1|1|1|vanR-C|vanR-C|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-C|AMR|glycopeptide	43.0	228	232	231	5.26e-56	177
k141_72594_16	NCBI|WP_222891057.1|1|1|vanR-P|vanR-P|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_response_regulator_transcription_factor_VanR-P|AMR|glycopeptide	39.3	234	232	239	6.68e-56	177
k141_72594_17	CARD|gb|AAD51347.1|ARO:3003067|smeS	29.9	291	505	467	3.33e-33	130
k141_72594_17	NCBI|WP_063856748.1|1|1|vanS-M|vanS-M|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-M|AMR|glycopeptide	28.9	308	505	370	2.40e-29	117
k141_72594_17	NCBI|WP_006285582.1|1|1|vanS-F|vanS-F|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-F|AMR|glycopeptide	26.6	290	505	365	4.33e-25	105
k141_72594_17	CARD|gb|AAC75429.1|ARO:3000833|evgS	30.8	227	505	1197	8.21e-25	107
k141_72594_17	NCBI|WP_063856734.1|1|1|vanS-E|vanS-E|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|glycopeptide_resistance_histidine_kinase_VanS-E|AMR|glycopeptide	27.1	221	505	357	1.03e-21	95.5
k141_72594_17	megares|MEG_7511|Drugs|Glycopeptide|VanE-type_regulator|VANSE_1	27.1	221	505	357	1.03e-21	95.5
k141_72594_25	megares|MEG_4106|Drugs|MLS|23S_rRNA_methyltransferases|MYRA_1	35.3	283	279	295	3.04e-34	124
k141_72594_25	SARG|gb|BAA03674.1|ARO:3001300|myrA	35.3	283	279	295	3.04e-34	124
k141_120769_5	SARG|gi|895819918|ref|WP_048943810.1|	21.6	236	253	498	2.51e-06	47.0
k141_120769_5	SARG|gi|498424272|ref|WP_010730861.1|	22.7	225	253	498	2.51e-06	47.0
k141_120769_5	SARG|gi|498524203|ref|WP_010823919.1|	21.6	236	253	498	3.36e-06	46.6
k141_120769_5	SARG|gi|498393490|ref|WP_010707193.1|	21.6	236	253	498	3.36e-06	46.6
k141_120769_5	SARG|gi|498399943|ref|WP_010713140.1|	21.6	236	253	498	3.36e-06	46.6
k141_120769_5	SARG|gi|488303094|ref|WP_002374069.1|	21.6	236	253	498	3.36e-06	46.6
k141_120769_5	SARG|gi|514908720|ref|WP_016633351.1|	21.6	236	253	498	3.36e-06	46.6
k141_120769_5	SARG|gi|498528849|ref|WP_010828356.1|	21.6	236	253	498	4.49e-06	46.2
k141_120769_5	SARG|gi|488324747|ref|WP_002394132.1|	21.6	236	253	498	4.49e-06	46.2
k141_120769_5	SARG|ZP_04433622	21.6	236	253	498	4.49e-06	46.2
k141_120769_15	SARG|gi|648667297|ref|WP_026359044.1|	29.5	570	798	605	1.15e-67	234
k141_120769_15	SARG|gi|501350226|ref|WP_012381861.1|	29.8	567	798	603	2.76e-66	230
k141_120769_15	SARG|gi|664170108|ref|WP_030704355.1|	29.8	567	798	603	5.25e-66	229
k141_120769_15	SARG|gi|490068471|ref|WP_003970646.1|	29.6	567	798	603	1.90e-65	228
k141_120769_15	SARG|gi|764446018|ref|WP_044369325.1|	29.1	547	798	605	3.76e-65	227
k141_120769_15	SARG|gi|695887424|ref|WP_032788534.1|	29.3	547	798	605	5.19e-65	227
k141_120769_15	SARG|gi|497748188|ref|WP_010062372.1|	29.4	547	798	605	5.19e-65	227
k141_120769_15	SARG|gi|664180077|ref|WP_030714054.1|	29.3	547	798	605	5.19e-65	227
k141_120769_15	SARG|gb|AAC74000.1|ARO:3003950|msbA	30.4	573	798	582	1.62e-64	225
k141_120769_15	SARG|gi|664042835|ref|WP_030582300.1|	29.1	567	798	604	1.83e-64	225
k141_245476_5	NCBI|WP_109545033.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	32.3	254	430	355	8.82e-25	103
k141_245476_5	megares|MEG_7602|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_1	32.3	254	430	355	8.82e-25	103
k141_245476_5	SARG|ACM47285	32.3	254	430	363	9.84e-25	103
k141_245476_5	megares|MEG_7603|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_1	30.9	256	430	355	3.63e-23	99.0
k141_245476_5	SARG|BAE96115	30.9	256	430	355	3.63e-23	99.0
k141_245476_5	NCBI|WP_063856871.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	28.8	274	430	346	1.11e-22	97.4
k141_245476_5	NCBI|WP_063856862.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	30.9	256	430	356	1.08e-21	94.7
k141_245476_5	megares|MEG_7604|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_2	32.8	198	430	209	2.81e-21	90.5
k141_245476_5	NCBI|WP_063856854.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	30.5	256	430	356	4.94e-21	92.8
k141_245476_5	NCBI|WP_049898469.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	30.5	256	430	356	4.94e-21	92.8
k141_245476_14	SARG|gb|CAH14033.1|ARO:3004100|LpeB	24.4	864	1310	1014	1.54e-46	181
k141_245476_14	CARD|gb|AAC75137.1|ARO:3000794|mdtC	25.1	861	1310	1025	6.01e-42	166
k141_245476_14	CARD|gb|AAL14440.1|ARO:3000775|adeB	23.9	790	1310	1035	1.02e-35	146
k141_245476_14	SARG|YP_348488	22.9	865	1310	1043	1.36e-35	146
k141_245476_14	SARG|YP_001668663	23.5	871	1310	1043	4.07e-35	144
k141_245476_14	SARG|gi|553791723|ref|WP_023122781.1|	24.2	872	1310	1043	1.69e-32	136
k141_245476_14	ResF|tmexD4_1_CP091084_1	22.5	876	1310	1044	2.93e-32	135
k141_245476_14	NCBI|WP_034065037.1|1|1|tmexD3|tmexD|efflux|2|TIGECYCLINE|TETRACYCLINE|multidrug_efflux_RND_transporter_permease_subunit_TMexD3|AMR|tetracycline	22.4	869	1310	1044	2.93e-32	135
k141_245476_14	NCBI|WP_027591160.1|1|1|tmexD2|tmexD|efflux|2|TIGECYCLINE|TETRACYCLINE|multidrug_efflux_RND_transporter_permease_subunit_TMexD2|AMR|tetracycline	22.5	876	1310	1044	3.85e-32	135
k141_245476_14	SARG|gi|489210576|ref|WP_003119403.1|	24.2	872	1310	1043	5.05e-32	134
k141_183824_5	NCBI|WP_109545033.1|1|1|vanY-D|vanY-D|re-structuring_of_the_cell_wall|2|VANCOMYCIN|GLYCOPEPTIDE|transpeptidase-like_D-Ala-D-Ala_carboxypeptidase_VanY-D|AMR|glycopeptide	28.8	274	415	355	8.94e-20	89.0
k141_183824_5	megares|MEG_7602|Drugs|Glycopeptide|VanD-type_accessory_protein|VANYD_1	28.8	274	415	355	8.94e-20	89.0
k141_183824_5	SARG|ACM47285	28.8	274	415	363	9.69e-20	89.0
k141_152874_5	SARG|gi|746253210|ref|WP_039301529.1|	36.3	314	1065	648	1.31e-48	183
k141_152874_5	SARG|gi|495736522|ref|WP_008461101.1|	36.3	314	1065	648	1.76e-48	182
k141_152874_5	SARG|gi|493734654|ref|WP_006683876.1|	37.9	301	1065	648	4.26e-48	181
k141_152874_5	SARG|gi|746243059|ref|WP_039291473.1|	36.8	315	1065	648	7.68e-48	181
k141_152874_5	SARG|gi|506220920|ref|WP_015740695.1|	37.3	314	1065	647	1.83e-47	179
k141_152874_5	SARG|gi|504542119|ref|WP_014729221.1|	36.9	314	1065	647	3.30e-47	179
k141_152874_5	SARG|gi|1001720867|ref|WP_061274204.1|	36.2	315	1065	648	3.35e-47	179
k141_152874_5	SARG|gi|938460528|ref|WP_054624864.1|	36.9	314	1065	647	4.43e-47	178
k141_152874_5	SARG|gi|1020141879|ref|WP_063264839.1|	36.9	314	1065	647	4.43e-47	178
k141_152874_5	SARG|gi|490522515|ref|WP_004387938.1|	36.9	314	1065	647	4.43e-47	178
k141_76902_2	megares|MEG_5396|Drugs|Aminocoumarins|Aminocoumarin-resistant_DNA_topoisomerases|PARY_1	30.1	691	664	703	2.00e-81	271
